Dr. KA LAM WONG, Hong Kong
Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor
Prof. Binnaz Handan Ozdemir, Turkey
Comparison of pure antibody-mediated rejection with mixed cellular and antibody-mediated rejection in regards to the pathological features, development of cardiac allograft vasculopathy (CAV) and cardiovascular mortality (CVM) in heart transplant patients
Prof. Minoru Ono, Japan
Does body size affect a successful bridge to heart transplantation by long-term continuous-flow ventricular assist device support?
Amrita Dosanjh
2020-09-15 15:10
Thank you for your presentation and interesting results. Please comment about the findings regarding smoking history.